Search results
VBI Vaccines Inc.'s (NASDAQ:VBIV) Intrinsic Value Is Potentially 30% Above Its Share Price
Simply Wall St. via Yahoo Finance· 1 year agoKey Insights The projected fair value for VBI Vaccines is US$3.70 based on 2 Stage Free Cash Flow to...
VBI Vaccine (VBIV) Inks Deal With Agenus for Brain Cancer Study
Zacks via Yahoo Finance· 2 years agoVBI Vaccines (VBIV) enters into a partnership with Agenus to conduct a study evaluating the former's...
VBI Vaccines, Inc. (VBIV) Reports Q3 Loss, Misses Revenue Estimates
Zacks via Yahoo Finance· 2 years agoVBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -12.50% and 75.48%,...
VBI Vaccines (VBIV) Down 53% on Initiating Restructuring Plans
Zacks via Yahoo Finance· 1 year agoVBI Vaccines (VBIV) will focus on its HBV vaccine product and advancing its HBV immunotherapeutic...
VBI Vaccines, Inc. (VBIV) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
Zacks via Yahoo Finance· 1 year agoVBI Vaccines, Inc. (VBIV) doesn't possess the right combination of the two key ingredients for a...
Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
Motley Fool· 2 years agoThe back half of 2022 is already shaping up to be a stock picker's market. Today's mixed trading...
7 Biotech Stocks to Sell in July
InvestorPlace via Yahoo Finance· 11 months agoBiotech may be a great sector for risk-seeking investors to find opportunity. That said, for every biotech stock worth buying, there are plenty that fit...